Fennec Pharmaceuticals (FENC) Operating Expenses (2010 - 2025)

Fennec Pharmaceuticals (FENC) has 16 years of Operating Expenses data on file, last reported at $16.3 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses rose 84.34% year-over-year to $16.3 million; the trailing twelve-month figure through Dec 2025 stood at $50.9 million (up 13.24% YoY), and the FY2025 full-year result was $50.9 million, up 13.24% from the prior year.
• Operating Expenses for Q4 2025 stood at $16.3 million, up from $12.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $16.3 million in Q4 2025 and bottomed at -$5.0 million in Q2 2022.
• The 5-year median for Operating Expenses is $7.9 million (2022), against an average of $8.1 million.
• The widest annual swing landed in 2022, when Operating Expenses tumbled 227.78%; it then jumped 259.53% in 2023.
• A 5-year view of Operating Expenses shows it stood at $4.2 million in 2021, then jumped by 80.27% to $7.6 million in 2022, then soared by 52.33% to $11.6 million in 2023, then dropped by 23.32% to $8.9 million in 2024, then soared by 84.34% to $16.3 million in 2025.
• The last three Operating Expenses figures came in at $16.3 million (Q4 2025), $12.7 million (Q3 2025), and $12.4 million (Q2 2025), per Business Quant data.

Peer Comparison